XNCR Q1 2024 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M-15.6% YoY

Gross Profit

$16M100.0% margin

Operating Income

-$55M-341.7% margin

Net Income

-$73M-459.1% margin

EPS (Diluted)

$-1.11

QoQ Revenue Growth

-68.6%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$56M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$897M

Total Liabilities

$297M

Stockholders' Equity

$600M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$19M	-15.6%
Gross Profit	$16M	-$47M	+134.3%
Operating Income	-$55M	-$61M	+10.0%
Net Income	-$73M	-$61M	-20.9%

Revenue Segments

Non-cash Royalty

$12M96%

Milestone

$500,0004%